MOUNTAIN VIEW, Calif., June 8 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has been invited to present at the 6th Annual Needham & Company Biotechnology and Medical Technology Conference, which will take place at the Palace Hotel in New York City, June 13-14, 2007. The Company will discuss its business strategy and overall performance on Thursday, June 14, 2007 at 1:30 p.m. Eastern Time. The presentation will be made by IRIDEX President and CEO, Barry G. Caldwell.
Attendance at the conference is by invitation only. IRIDEX will offer a live audio webcast of its presentation, which may be accessed at the Company's website at http://www.iridex.com. An archived replay of the presentation will be available following the live presentation and will also be available at http://www.iridex.com for 90 days.
About IRIDEX
IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 97 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.
Contact:
Larry Tannenbaum
Chief Business Officer
650-940-4700
SOURCE IRIDEX Corporation
06/08/2007
CONTACT: Larry Tannenbaum, Chief Business Officer of IRIDEX Corporation,
+1-650-940-4700
Web site: http://www.iridex.com
(IRIX)
